Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They mentioned they might
They should apply to NYSE ASAP for backup imo
CW has no convert debt nor would they imo.
Wow CVSI said they dont think big retailers are waiting on the FDA to jump into the space.
Its the northland guy with the $8 target
CVSI said overall market will grow to $12-$16 Billion
its the Northland guy with the $8 target
CVSI just said self affirmed GRAS no advantage right now with retailers, but they think that will change with FDA framework. CW well on their way in this process also.
I think the problem for them was having CBD on the label.
CW so smart to not have CBD on label.
CVSI is out. They are doing well but CW seems way ahead in store count ( 1500 more stores ) and overall revs. Not a knock on CVSI at all. revs they did 13.6m in q3 and 14.2m in q4
NATIONAL CANCER INSTITUTE'S SHARPLESS TO BE ACTING FDA HEAD
He's cannabis friendly, according to @reddit first blush
isnt this patent potentially massive ?
Patent situation could end up being huge here
SBI intends to explore research and development opportunities for CBD products through pre-clinical and clinical trials and is currently
supporting non-profit organizations to accomplish this goal.
United States Patents – SBI has a portfolio of U.S. plant, utility and design patent applications pending:
Patent Application Title
Hemp Plant Named ‘CW2A’
Cannabinoid Extractor
Cannabidiol/Cannabinoids/CBDA and Diabetes
40 The Company currently uses select contract manufacturers for topicals and capsules who manufacture products according to the Company’s
specifications and standards.
- 44 -
Apparatuses, methods, and systems for extraction, isolation and conversion of various
cannabinoids, and modifications of whole-plant cannabis sativa extracts therewith
Apparatuses, methods, and systems for extraction, isolation and conversion of various
cannabinoids, and modifications of whole-plant hemp extracts therewith
Apparatuses, methods and systems for compound-specific supercritical extraction of hemp
Apparatuses, methods and systems for compound-specific supercritical extraction of hemp
Hemp Varieties with Improved Agronomic Characteristics
These patent applications cover the Corporation’s most promising plant genetics, as well as proprietary
extraction and cannabinoid isolation and conversion processes and designs.
Wow patent pending? this would be massive ? The Stanleys want to stake a claim to the strain. “We’re going to be genetically sequencing Charlotte’s Web to try to patent the plant,” Jesse says.
volume picking up
low volume upswing continues
So they may be holding the results ?
Yes and everyone would have to relabel except CW if that were to happen . But this also shows CW is very in tune with the FDA . Current CEO is ex FDA guy also
A significant looming potential risk is that the FDA may decide to eliminate any labeling and
marketing that includes “CBD” in its wording.
CW would be only one no CBD in label. Also note CVS already has hemp products but nothing with CBD
https://www.cvs.com/search/?searchTerm=hemp
CVS and Walgreens each have just under 10k locations
We are doing 70m approx for 2018 and 120-170m in 2019....approx 3k stores........what happens to #'s when mass retail opens up and we are in 20k+ stores?
yes like 1m shares short between the two exchanges. CSE trades so thin could be TLRY type squeeze
Recent Roth Capital report -> We believe CBD could garner 10-15% market share in many of the categories with a potential estimated U.S.
CBD market to reach $31 -$46B over time.
Two highlights from Roth report: We believe CBD could garner 10-15% market share in many of the categories with a potential estimated U.S.
CBD market to reach $31 -$46B over time.
and:
A significant looming potential risk is that the FDA may decide to eliminate any labeling and
marketing that includes “CBD” in its wording.
CW only CBD play I know that does not have CBD in label.
I think CW is well through the process themselves
I dont think chart matters at this point....the report is what matters and even more importantly future guidance/plans which i expect to be good. Would imagine they are asked / or address the uplist. Most likely will say they are in talks or pursuing it etc.
very low volume day
likely the path imo
The industry wants CBD listed as "generally recognized as safe," so it would be classified similarly to vanilla flavoring and caffeine. Joining the industry in this push are at least a dozen lawmakers, who have asked the FDA to reconsider its policy on CBD in food so that it can be manufactured and sold without FDA approval. Gottlieb has shown signs of softening his position. He recently told Congress he would hold the first public hearings on CBD in April, en route to developing formal guidelines.
However the hearings play out, CBD-infused products aren’t going away. Today, nearly 7% of American adults use CBD products. That number is expected to grow to 10% over the next several years, and as CBD continues gaining popularity, it will continue to attract even greater numbers of new consumers into the market.
https://www.forbes.com/sites/nickkovacevich/2019/03/06/with-cbd-cannabis-wellness-market-goes-big/#241facd43fcb
Do they work as well as the oil drops ? I know it depends on strength but in general
This is my first CVSI ER , do they do a conference call with a Q&A session ?
Besides gummies new pet products were introduced
Probably gummy pr Monday perhaps
Yes I believe they have met with like 130 of the worlds top funds , some managing trillions
CBD still on form ground despite FDA head resigning
https://www.inverse.com/article/53902-now-that-scott-gottlieb-is-gone-will-cbd-be-illegal
Why no PR? Here is link:
https://www.facebook.com/348267158692701/posts/1092581340927942/